RI-MUHC Annual Report
Cellular Therapy Laboratory (CTL)The Cellular Therapy Laboratory (CTL) at the RI-MUHC was created to enhance research capabilities using...
What's New at the RI-MUHC ?
Congratulations to Tho-Alfakar Al-Aubodah!
RI-MUHC scientist Dr. Cecilia Costiniuk is co-principal investigator in a new national study that hopes to answer critical questions around the...
Mobile application EczemaQ wins the Hakim Family Innovation Prize. Remote Optical and Nura Medical were...
Canadian Bioethics Society honours a researcher who promotes the human right of every citizen to benefit from science and its applications
Specialized cells called pericytes play a key role, reveals new work from researchers at the RI-MUHC
Next-generation gene sequencing may provide answers for some women dealing with recurrent pregnancy loss and prevent further miscarriages
A team of researchers at the RI-MUHC found two cellular pathways involved in TNBC tumour development...
New target for cystic fibrosis drug development: Ceramides
Bringing an innovative retinal gene therapy to clinic
Speakers: Dr. Jason M. Harley (Principal Investigator, Department of Surgery) and Dr. Elif Bilgic (Postdoctoral Fellow)
Success storiesThese are just a few examples of recent successes in business development at the RI-MUHC.Bringing a C-diff predictive...
Contact usWe welcome inquiries about Business Development Office services. Please email us: email@example.com
Topic: Perspectives on a Life in Lipids
CLIP leadershipLiane Feldman, MDMedical Director, CLIPDr. Feldman is an investigator in the Injury Repair Recovery Program at the...
Work published in Nature Communications demonstrates a...
RI-MUHC researcher Ciriaco Piccirillo takes a leading role in Canada’s new Coronavirus Variants Rapid Response Network
In virtual (zoom) and face-to-face format in Sherbrooke and in the 3 participating centers.
Louise Pilote receives international award for Research in Cardiovascular Health and Disease in Women
The International Society of Hypertension honours the RI-MUHC...
Congratulations to Dr. Julia Valdemarin Burnier!
Topic: Developing a core outcome set for diabetes after pregnancy prevention trials: the COS-DAP project
— 25 Items per Page